Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7860)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 15, 2019 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Berghella AM, Aureli A, Canossi A, Beato TD, Colanardi A, Pellegrini P. Redox, immune and genetic biomarker system for personalized treatments in colorectal cancer. World J Gastrointest Oncol 2019; 11(2): 117-138 [PMID: 30788039 DOI: 10.4251/wjgo.v11.i2.117] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i2/117.htm |
| Number | Citing Articles |
| 1 |
Daniela Piancatelli, Anna Aureli, Pierluigi Sebastiani, Alessia Colanardi, Tiziana Del Beato, Lorenza Del Cane, Patrizia Sucapane, Carmine Marini, Silvia Di Loreto. Gene- and Gender-Related Decrease in Serum BDNF Levels in Alzheimer’s Disease. International Journal of Molecular Sciences 2022; 23(23): 14599 doi: 10.3390/ijms232314599
|
| 2 |
Sara Tirendi, Barbara Marengo, Cinzia Domenicotti, Anna M. Bassi, Vanessa Almonti, Stefania Vernazza. Colorectal cancer and therapy response: a focus on the main mechanisms involved. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1208140
|
| 3 |
Angelica Canossi, Anna Aureli, Tiziana Del Beato, Giorgio Novelli, Oreste Buonomo, Piero Rossi, Adriano Venditti, Franco Papola, Giuseppe Sconocchia. Impact of HLA Class I Antigen, Killer Inhibitory Receptor, and
FCGR3A Genotypes on Breast Cancer Susceptibility and Tumor
Stage. Current Molecular Medicine 2024; 24(7): 920 doi: 10.2174/1566524023666230717162458
|